乳腺癌中的胰岛素受体：生物学及临床作用 - Suppr

Suppr

超能文献

Insulin receptors in breast cancer: biological and clinical role.

作者信息

Papa V, Belfiore A

机构信息

Cattedra di Endocrinologia, Ospedale Garibaldi, University of Catania, Italy.

出版信息

J Endocrinol Invest. 1996 May;19(5):324-33. doi: 10.1007/BF03347871.

DOI:10.1007/BF03347871

PMID:8796343

Abstract

摘要

相似文献

Insulin receptors in breast cancer: biological and clinical role.乳腺癌中的胰岛素受体：生物学及临床作用

J Endocrinol Invest. 1996 May;19(5):324-33. doi: 10.1007/BF03347871.

Receptors for insulin and insulin-like growth factors in disease.疾病中的胰岛素及胰岛素样生长因子受体

Adv Biochem Psychopharmacol. 1980;21:489-97.

The role of pituitary hormones, growth factors and insulin in the regulation of fetal growth.垂体激素、生长因子和胰岛素在胎儿生长调节中的作用。

Oxf Rev Reprod Biol. 1986;8:1-60.

[Insulin as a growth factor].[胰岛素作为一种生长因子]

Nihon Rinsho. 1997 Nov;55 Suppl:844-8.

[Insulin receptors: activators and signalling].[胰岛素受体：激活剂与信号传导]

Journ Annu Diabetol Hotel Dieu. 1993:1-10.

A proteolytic mechanism for the action of insulin via oligopeptide mediator formation.一种通过寡肽介质形成实现胰岛素作用的蛋白水解机制。

Fed Proc. 1982 Sep;41(11):2724-9.

The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy?胰岛素样生长因子与胰岛素信号系统：乳腺癌治疗的一个有吸引力的靶点？

Horm Metab Res. 2003 Nov-Dec;35(11-12):857-71. doi: 10.1055/s-2004-814142.

Molecular components common to the immune system and neurons: growth factors and their receptors.免疫系统和神经元共有的分子成分：生长因子及其受体。

Adv Biochem Psychopharmacol. 1988;44:21-33.

The biological and clinical roles of increased insulin receptors in human breast cancer.胰岛素受体增加在人类乳腺癌中的生物学及临床作用

Cancer Treat Res. 1992;63:193-209. doi: 10.1007/978-1-4615-3088-6_9.

Receptors for insulin and other growth factors: rationale for common and distinct mechanisms of cell activation.胰岛素及其他生长因子的受体：细胞激活的共同与不同机制的基本原理

Clin Invest Med. 1987 Sep;10(5):475-9.

引用本文的文献

The effect of BMI on survival outcome of breast cancer patients: a systematic review and meta-analysis.体重指数对乳腺癌患者生存结局的影响：一项系统评价与荟萃分析。

Clin Transl Oncol. 2025 Feb;27(2):403-416. doi: 10.1007/s12094-024-03563-9. Epub 2024 Jul 16.

Body composition and cancer survival: a narrative review.人体成分与癌症生存：叙述性综述。

Br J Cancer. 2024 Feb;130(2):176-183. doi: 10.1038/s41416-023-02470-0. Epub 2023 Oct 27.

The relationship between women's body mass index and breast cancer outcomes was U-shaped.女性体重指数与乳腺癌预后之间的关系呈U形。

Front Oncol. 2023 May 25;13:1191093. doi: 10.3389/fonc.2023.1191093. eCollection 2023.

Visceral Adiposity and Cancer: Role in Pathogenesis and Prognosis.内脏脂肪与癌症：在发病机制和预后中的作用。

Nutrients. 2021 Jun 19;13(6):2101. doi: 10.3390/nu13062101.

Breast cancer risk factors and their effects on survival: a Mendelian randomisation study.乳腺癌风险因素及其对生存的影响：一项孟德尔随机化研究。

BMC Med. 2020 Nov 17;18(1):327. doi: 10.1186/s12916-020-01797-2.

Breast Cancer Primary Prevention and Diet: An Umbrella Review.乳腺癌一级预防与饮食：伞式评价。

Int J Environ Res Public Health. 2020 Jul 1;17(13):4731. doi: 10.3390/ijerph17134731.

Improving health engagement and lifestyle management for breast cancer survivors with diabetes.提高患有糖尿病的乳腺癌幸存者的健康参与度和生活方式管理。

Contemp Clin Trials. 2020 May;92:105998. doi: 10.1016/j.cct.2020.105998. Epub 2020 Apr 11.

The Performance of Different Artificial Intelligence Models in Predicting Breast Cancer among Individuals Having Type 2 Diabetes Mellitus.不同人工智能模型在预测2型糖尿病患者患乳腺癌风险中的表现

Cancers (Basel). 2019 Nov 8;11(11):1751. doi: 10.3390/cancers11111751.

Docosahexaenoic Acid in Combination with Dietary Energy Restriction for Reducing the Risk of Obesity Related Breast Cancer.二十二碳六烯酸联合饮食能量限制减少肥胖相关乳腺癌的风险。

Int J Mol Sci. 2017 Dec 22;19(1):28. doi: 10.3390/ijms19010028.

High glucose and high insulin conditions promote MCF‑7 cell proliferation and invasion by upregulating IRS1 and activating the Ras/Raf/ERK pathway.高葡萄糖和高胰岛素条件通过上调 IRS1 并激活 Ras/Raf/ERK 通路促进 MCF-7 细胞增殖和侵袭。

Mol Med Rep. 2017 Nov;16(5):6690-6696. doi: 10.3892/mmr.2017.7420. Epub 2017 Aug 31.

本文引用的文献

BRCA1--lots of mutations, lots of dilemmas.乳腺癌1号基因（BRCA1）——突变众多，困境重重。

N Engl J Med. 1996 Jan 18;334(3):186-8. doi: 10.1056/NEJM199601183340311.

Growth factors in breast cancer.乳腺癌中的生长因子

Endocr Rev. 1995 Oct;16(5):559-89. doi: 10.1210/edrv-16-5-559.

Structural and functional studies of insulin receptors in human breast cancer.人类乳腺癌中胰岛素受体的结构与功能研究

Breast Cancer Res Treat. 1993;25(1):73-82. doi: 10.1007/BF00662403.

Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity.纯化的杂合胰岛素/胰岛素样生长因子-I受体以高亲和力结合胰岛素样生长因子-I，但不结合胰岛素。

Biochem J. 1993 Mar 1;290 ( Pt 2)(Pt 2):419-26. doi: 10.1042/bj2900419.

Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene.通过转染人MET原癌基因将促运动和侵袭反应转移至分散因子/肝细胞生长因子

Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):649-53. doi: 10.1073/pnas.90.2.649.

Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer.胰岛素样生长因子-I受体在人类乳腺癌中过度表达并预示低风险。

Cancer Res. 1993 Aug 15;53(16):3736-40.

Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors.表达胰岛素样生长因子-1（IGF-1）受体反义RNA的大鼠胶质母细胞瘤细胞无致瘤性，并可诱导野生型肿瘤消退。

Cancer Res. 1994 Apr 15;54(8):2218-22.

Insulin-resistant MDA-MB231 human breast cancer cells contain a tyrosine kinase inhibiting activity.胰岛素抵抗的MDA-MB231人乳腺癌细胞含有一种酪氨酸激酶抑制活性。

Mol Endocrinol. 1993 Dec;7(12):1667-76. doi: 10.1210/mend.7.12.8145772.

The role of the insulin-like growth factor I receptor in the transformation by simian virus 40 T antigen.胰岛素样生长因子I受体在猿猴病毒40 T抗原介导的转化过程中的作用。

Oncogene. 1994 Mar;9(3):825-31.

EGF receptor expression, regulation, and function in breast cancer.表皮生长因子受体在乳腺癌中的表达、调控及功能

Breast Cancer Res Treat. 1994 Jan;29(1):29-40. doi: 10.1007/BF00666179.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验